Document is current
Any future updates will be listed below
-
Authors
Rolfo, Christian https://orcid.org/0000-0002-7860-8417
Russo, Alessandro https://orcid.org/0000-0002-3365-1972
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05306288 at ClinicalTrials.govnct04825834 at ClinicalTrials.govDocuments that mention this clinical trial
Brave new world of cfDNA-omics for early cancer detection
https://doi.org/10.1136/jitc-2022-006309
nct05611632 at ClinicalTrials.govDocuments that mention this clinical trial
Brave new world of cfDNA-omics for early cancer detection
https://doi.org/10.1136/jitc-2022-006309
Prospective evaluation of cell-free DNA fragmentation profiles for lung cancer detection.
https://doi.org/10.1200/jco.2023.41.16_suppl.e20521
nct05205967 at ClinicalTrials.govDocuments that mention this clinical trial
Psychological Impact of the Galleri test (sIG(n)al): protocol for a longitudinal evaluation of the psychological impact of receiving a cancer signal in the NHS-Galleri trial
https://doi.org/10.1136/bmjopen-2023-072657
Brave new world of cfDNA-omics for early cancer detection
https://doi.org/10.1136/jitc-2022-006309
Impact of screening participation on modelled mortality benefits of a multi-cancer early detection test by socioeconomic group in England
https://doi.org/10.1136/jech-2023-220834
nct03085888 at ClinicalTrials.govDocuments that mention this clinical trial
Brave new world of cfDNA-omics for early cancer detection
https://doi.org/10.1136/jitc-2022-006309
nct03934866 at ClinicalTrials.govDocuments that mention this clinical trial
Brave new world of cfDNA-omics for early cancer detection
https://doi.org/10.1136/jitc-2022-006309
nct04213326 at ClinicalTrials.govDocuments that mention this clinical trial
Upstaging of screen-detected lung cancers during diagnostic assessment
https://doi.org/10.1136/thorax-2025-224006
Prevalence and clinical characteristics of non-malignant CT detected incidental findings in the SUMMIT lung cancer screening cohort
https://doi.org/10.1136/bmjresp-2023-001664
S76 The SUMMIT study: four-week quit rates amongst individuals referred to stop smoking services following attendance at a lung health check
https://doi.org/10.1136/thorax-2023-btsabstracts.82
Differentiating clinically important interstitial lung abnormalities in lung cancer screening
https://doi.org/10.1136/bmjresp-2025-003298
Growing small solid nodules in lung cancer screening: safety and efficacy of a 200 mm<sup>3</sup>minimum size threshold for multidisciplinary team referral
https://doi.org/10.1136/thorax-2022-219403
Delivering low-dose CT screening for lung cancer: a pragmatic approach
https://doi.org/10.1136/thoraxjnl-2020-215131
Performance of volume and diameter thresholds in malignancy prediction of solid nodules in lung cancer screening
https://doi.org/10.1136/thorax-2024-222086
P100 Impact of the COVID-19 pandemic on health services utilisation in a lung cancer screening cohort
https://doi.org/10.1136/thorax-2021-btsabstracts.209
S67 Association of airflow obstruction identified at lung cancer screening with major adverse cardiovascular events
https://doi.org/10.1136/thorax-2025-btsabstracts.73
P155 Interobserver variability in cause of death in a lung cancer screening trial: a pilot method study
https://doi.org/10.1136/thorax-2024-btsabstracts.316
S135 Comparing changes in solid component diameter and mass for detecting invasive adenocarcinoma in sub-solid pulmonary nodules (SSNs): the SUMMIT study
https://doi.org/10.1136/thorax-2024-btsabstracts.140
P161 Recruitment from lung cancer screening to a COPD clinical trial
https://doi.org/10.1136/thorax-2024-btsabstracts.322
Brave new world of cfDNA-omics for early cancer detection
https://doi.org/10.1136/jitc-2022-006309
Uptake and 4-week outcomes of an ‘opt-out’ smoking cessation referral strategy in a London-based lung cancer screening setting
https://doi.org/10.1136/bmjresp-2024-002337
Documents that mention this clinical trial
Brave new world of cfDNA-omics for early cancer detection
https://doi.org/10.1136/jitc-2022-006309
- License Information
